Download MendeleyStructural snapshots of Pseudomonas aeruginosa LptB 2 FG and LptB 2 FGC reveal insights into lipopolysaccharide recognition and transport.
Fiorentino, F., Cervoni, M., Wang, Y., Urner, L.H., Sauer, J.B., Tran, A., Corey, R.A., Rotili, D., Mai, A., Stansfeld, P.J., Imperi, F., Yu, E.W., Su, C.C., Robinson, C.V., Bolla, J.R.(2025) Nat Commun 16: 11384-11384
- PubMed: 41407669 Search on PubMedSearch on PubMed Central
- DOI: https://doi.org/10.1038/s41467-025-66182-0
- Primary Citation Related Structures:
9DOH, 9DOK, 9DOO, 9DOQ, 9DOR - PubMed Abstract:
Gram-negative bacteria are intrinsically resistant to many antibiotics because of densely packed lipopolysaccharides (LPS) in the outer leaflet of their outer membrane (OM), which acts as a highly effective barrier towards the spontaneous permeation of toxic molecules, including antibiotics. LPS are extracted from the inner membrane by the ABC transporter LptB 2 FGC and translocated across the periplasm via a protein bridge to the OM. While structural studies have elucidated aspects of Lpt function in enterobacteria, little is known about how this system operates in divergent species such as Pseudomonas aeruginosa, a major human pathogen. Here, we report five cryo-electron microscopy structures of P. aeruginosa LptB 2 FG and LptB 2 FGC, revealing a rigid body movement in the periplasmic β-jellyroll domains necessary for LPS to shuttle through the periplasmic space. Notably, these structures exhibit a significantly smaller LPS binding cavity compared to previously determined models, suggesting the ligand-unbound states of the transporter. Mass spectrometry and molecular dynamics simulations indicate that the phosphate groups of LPS are the key determinants for binding and that the transporter can also accommodate cardiolipin. Together, these findings reveal previously unappreciated structural diversity in the Lpt system and provide mechanistic insight into how pathogenic Gram-negative bacteria tailor LPS recognition and transport. This understanding offers new avenues for the development of novel inhibitors targeting membrane biogenesis.
- Department of Biochemical Sciences, Sapienza University of Rome, Rome, Italy.
Organizational Affiliation:
